Rockville, MD -- (SBWIRE) -- 08/13/2019 -- In order to dissert the market scenario prevailing across the aptamers market sector, Fact.MR has evenly presented a comprehensive analysis report on aptamers market to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the aptamers market in the coming years. In addition, factors such as market size, Y-o-Y growth and revenue share are investigated so as to make this research highly authentic and reliable.
Get a Free Sample Report from Here – https://www.factmr.com/connectus/sample?flag=S&rep_id=173
Aptamers can be generated quickly as compared to antibodies which is a plus point and hence they are used widely in treating diseases. The global aptamers market is expected to witness a probable increase in demand and hence growth which is influenced by factors associated with the aptamer product. The increase in the research and development activities along with increase in the investments in the biotechnological and pharmaceutical companies has driven the use of aptamers and hence the global aptamer market. Other advantages such as technological advancements followed by patent expiration of SELEX (Systematic Evolution of Ligands by Exponential enrichment technology), is likely to boost the growth of the aptamers market on a global scale. The development in aptamers technology has brought more effective, efficient and cost-reduced process for binding larger molecules as compared to antibodies. This is another aspect contributing to the growth of the global aptamers market. Also, the increasing use of aptamers in disease treatment and drug discovery have a significant impact ensuring its growth in a positive direction.
Aptamers are peptide molecules or oligonucleotides which bind to a target lipid, nucleic acid molecules or proteins. They are rapidly generated and applied in the specific detection, inhibition and characterization of proteins. They are used as detecting reagents, can be used as functional proteomic levels with antibodies, can be used as small molecules as well as pharmaceutical leads. They also can be engineered to attain higher affinity to a large number of target groups. Aptamers can be generated much faster than antibodies and hence can be used to cure diseases much faster than antibodies.
The peptide segment by product type has high potential as it grows at a super exponential rate and is anticipated to reflect a CAGR of 30.1% during the period of forecast of 2017 to 2022 and a high gain in the BPS by the end of 2022. The DNA segment shows high market share by value as of 2017, thereby establishing dominance over other segments. However, the current rate of peptide segment can take it up a notch to actually match the market share of DNA segment. The XNA and RNA segments have more or less similar growth rates during the forecast period. DNA, RNA and XNA, however, bound to experience loss in the BPS by the end of 2022.
The North America region is supposed to be highly lucrative region for the aptamers market and shows a high market attractiveness index. With respect to revenue in 2017, the North America region is expected to dominate the global market and this trend is poised to continue over the forecast period. The region is expected to grow at a high growth rate to reflect a CAGR of 26.3% during the period of forecast. North America region is the largest market for all types of segments of the aptamers market. Following North America, Europe region also shows good growth potential in the aptamers market. The main reason for North America to prosper in this market is the technological advancement and the level of development that has taken place. The research and development centers also receive high investment support which make the most of them.
The academic and research centers by end user type are growing at a very high rate and poised to show a CAGR of 26.4% during the period of forecast. The pharmaceutical companies and the contract research organization (CRO) segments are expected to grow alongside one another, and are expected to show similar growth rates throughout the period of forecast. The bio-pharmaceutical companies segment shows the highest market share by revenue in 2017, and thereby dominates the global market and also reflects to gain a comparatively high BPS by the end of 2022.
Aptamers Market: Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of the global aptamers market through 2022, which include AM Biotech, Aptagen, LLC, Aptamer Sciences, Inc., Aptamer Group, Aptus Biotech, Base Pair Biotechnologies, Inc., NeoVentures Biotechnology Inc., Somalogic, Inc., TriLink BioTechnologies, LLC and Vivonics Inc.
Ask Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=173
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Suite 400, Rockville, MD 20852
Read Industry News at: https://insiderstribune.com